Search Within

Sarat Chandarlapaty

Formats
  1. Meeting Abstract (143)
  2. Journal Article (128)
  3. Review (9)
  4. Editorial (3)
  5. Guidelines (2)
  6. Book Section (1)
  7. Research Letter (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (287)
  2. Breast Medicine Service (287)
  3. Department of Medicine (287)
  4. GSK Faculty (287)
  5. Human Oncology and Pathogenesis Program (287)
  6. Solid Tumor Oncology Division (287)

More Groups

People
  1. Pedram Razavi (79)
  2. Jorge Reis-Filho (65)
  3. Neal Rosen (58)
  4. Shanu Modi (51)
  5. Jose Baselga (48)
  6. Britta Weigelt (43)

More People

Years
  1. 2025 (17)
  2. 2024 (30)
  3. 2023 (17)
  4. 2022 (25)
  5. 2021 (23)
  6. 2020 (33)

More Years

Publications
  1. Cancer Research (65)
  2. Journal of Clinical Oncology (53)
  3. Annals of Oncology (21)
  4. Cancer Discovery (11)
  5. Clinical Cancer Research (11)
  6. Laboratory Investigation (11)

More Publications

Publishers
  1. American Association for Cancer Research (90)
  2. American Society of Clinical Oncology (57)
  3. Nature Publishing Group (38)
  4. Oxford University Press (24)
  5. Cell Press (14)
  6. Elsevier Inc. (11)

More Publishers

Results (287)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic alterations targeting KIT in breast cancer
    Meeting Abstract

    Vahdatinia, M.; Lorenzo, F.; Ross, D.; Zehir, A.; Wen, H.; Brogi, E.; Weigelt, B.; Chandarlapaty, S.; Razavi, P.; Reis-Filho, J.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • MET gene amplification in breast cancer
    Meeting Abstract

    Maldonado, L.; Lorenzo, F.; Vahdatinia, M.; Ross, D.; Zehir, A.; Wen, H.; Brogi, E.; Weigelt, B.; Chandarlapaty, S.; Razavi, P.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Androgen receptor splicing variant-7 in breast carcinoma: Clinical and pathologic correlations
    Meeting Abstract

    Ferguson, D.; Mata, D.; Chandarlapaty, S.; Brogi, E.; Ladanyi, M.; Arcila, M.; Benayed, R.; Ross, D.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Efficacy and determinants of response to HER kinase inhibition in HER2-mutant metastatic breast cancer
    Journal Article

    Smyth, L. M.; Piha-Paul, S. A.; Won, H. H.; Schram, A. M.; Saura, C.; Loi, S.; Lu, J.; Shapiro, G. I.; Juric, D.; Mayer, I. A.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Development of genome-derived tumor type prediction to inform clinical cancer care
    Journal Article

    Penson, A.; Camacho, N.; Zheng, Y.; Varghese, A. M.; Al-Ahmadie, H.; Razavi, P.; Chandarlapaty, S.; Vallejo, C. E.; Vakiani, E.; Gilewski, T.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late recurrence: Current understanding, clinical considerations
    Review

    Dowling, R. J. O.; Kalinsky, K.; Hayes, D. F.; Bidard, F. C.; Cescon, D. W.; Chandarlapaty, S.; Deasy, J. O.; Dowsett, M.; Gray, R. J.; Henry, N. L.; more...
    JNCI Cancer Spectrum (2019)

    Fulltext@MSK | Save
  • Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to predict and identify late recurrence, research directions
    Review

    Dowling, R. J. O.; Sparano, J. A.; Goodwin, P. J.; Bidard, F. C.; Cescon, D. W.; Chandarlapaty, S.; Deasy, J. O.; Dowsett, M.; Gray, R. J.; Henry, N. L.; more...
    JNCI Cancer Spectrum (2019)

    Fulltext@MSK | Save
  • Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Ka inhibitors
    Journal Article

    Vasan, N.; Razavi, P.; Johnson, J. L.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Lin, T. Y.; Toska, E.; more...
    Science (2019)

    Fulltext@MSK | Save
  • Molecular profiling of ER plus metastatic breast cancers to reveal association of genomic alterations with acquired resistance to CDK4/6 inhibitors
    Meeting Abstract

    Razavi, P.; dos Anjos, C. H.; Brown, D. N.; Qing, L.; Ping, C.; Herbert, J.; Colon, J.; Liu, D.; Mao, M.; Norton, L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A large retrospective analysis of CDK 4/6 inhibitor retreatment in ER+ metastatic breast cancer (MBC)
    Meeting Abstract

    dos Anjos, C. H.; Razavi, P.; Herbert, J.; Colon, J.; Gill, K.; Modi, S.; Bromberg, J.; Dang, C. T.; Liu, D.; Norton, L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save